Skip to main content

Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model.

Publication ,  Journal Article
Manook, M; Flores, WJ; Schmitz, R; Fitch, Z; Yoon, J; Bae, Y; Shaw, B; Kirk, A; Harnois, M; Permar, S; Farris, AB; Magnani, DM; Kwun, J; Knechtle, S
Published in: Front Immunol
2021

BACKGROUND: In transplantation, plasmapheresis and IVIg provide the mainstay of treatment directed at reducing or removing circulating donor-specific antibody (DSA), yet both have limitations. We sought to test the efficacy of targeting the IgG recycling mechanism of the neonatal Fc receptor (FcRn) using anti-FcRn mAb therapy in a sensitized non-human primate (NHP) model, as a pharmacological means of lowering DSA. METHODS: Six (6) rhesus macaque monkeys, previously sensitized by skin transplantation, received a single dose of 30mg/kg anti-RhFcRn IV, and effects on total IgG, as well as DSA IgG, were measured, in addition to IgM and protective immunity. Subsequently, 60mg/kg IV was given in the setting of kidney transplantation from skin graft donors. Kidney transplant recipients received RhATG, and tacrolimus, MMF, and steroid for maintenance immunosuppression. RESULTS: Circulating total IgG was reduced from a baseline 100% on D0 to 32.0% (mean, SD ± 10.6) on d4 post infusion (p<0.05), while using a DSA assay. T-cell flow cross match (TFXM) was reduced to 40.6±12.5% of baseline, and B-cell FXCM to 52.2±19.3%. Circulating total IgM and DSA IgM were unaffected by treatment. Pathogen-specific antibodies (anti-gB and anti-tetanus toxin IgG) were significantly reduced for 14d post infusion. Post-transplant, circulating IgG responded to anti-FcRn mAb treatment, but DSA increased rapidly. CONCLUSION: Targeting the FcRn-mediated recycling of IgG is an effective means of lowering circulating donor-specific IgG in the sensitized recipient, although in the setting of organ transplantation mechanisms of rapid antibody rise post-transplant remains unaffected.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Front Immunol

DOI

EISSN

1664-3224

Publication Date

2021

Volume

12

Start / End Page

660900

Location

Switzerland

Related Subject Headings

  • Tissue Donors
  • Receptors, Fc
  • Models, Animal
  • Male
  • Macaca mulatta
  • Kidney Transplantation
  • Isoantibodies
  • Immunosuppressive Agents
  • Immunosuppression Therapy
  • Immunoglobulins, Intravenous
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Manook, M., Flores, W. J., Schmitz, R., Fitch, Z., Yoon, J., Bae, Y., … Knechtle, S. (2021). Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model. Front Immunol, 12, 660900. https://doi.org/10.3389/fimmu.2021.660900
Manook, Miriam, Walter J. Flores, Robin Schmitz, Zachary Fitch, Janghoon Yoon, Yeeun Bae, Brian Shaw, et al. “Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model.Front Immunol 12 (2021): 660900. https://doi.org/10.3389/fimmu.2021.660900.
Manook M, Flores WJ, Schmitz R, Fitch Z, Yoon J, Bae Y, et al. Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model. Front Immunol. 2021;12:660900.
Manook, Miriam, et al. “Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model.Front Immunol, vol. 12, 2021, p. 660900. Pubmed, doi:10.3389/fimmu.2021.660900.
Manook M, Flores WJ, Schmitz R, Fitch Z, Yoon J, Bae Y, Shaw B, Kirk A, Harnois M, Permar S, Farris AB, Magnani DM, Kwun J, Knechtle S. Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model. Front Immunol. 2021;12:660900.

Published In

Front Immunol

DOI

EISSN

1664-3224

Publication Date

2021

Volume

12

Start / End Page

660900

Location

Switzerland

Related Subject Headings

  • Tissue Donors
  • Receptors, Fc
  • Models, Animal
  • Male
  • Macaca mulatta
  • Kidney Transplantation
  • Isoantibodies
  • Immunosuppressive Agents
  • Immunosuppression Therapy
  • Immunoglobulins, Intravenous